Worldwide Recall On Allergan Textured Breast Implants
Executive Summary
Allergan PLC announced that it would take its Biocell textured breast implants and tissue expanders off the market worldwide shortly after the US FDA released additional information linking the use of the implants to a rare cancer.
You may also be interested in...
More Cancer Cases Tied To Breast Implants, FDA Says
The US agency announced this week that it’s reviewing multiple reports of a form of carcinoma that arises in the scar tissue around a breast implant.
FDA Strengthens Safety Requirements For Breast Implants
The US FDA has approved new labeling for all legally marketed breast implants that includes a boxed warning of potential risks. The agency also released updated information on the status of implant manufacturer post-approval studies.
Judge OKs Class-Action Suit From Allergan Investors
The lawsuit says that Allergan repeatedly downplayed the cancer risk its textured breast implants posed as compared to those from other manufacturers.